LSD Antibody
Ref. 3D-10-2881
| 1mg | Arrêté |
Informations sur le produit
The LSD Antibody is a highly effective and cytotoxic monoclonal antibody that specifically targets the amide racemase enzyme. This antibody has been extensively studied for its potential in cancer treatment due to its ability to selectively bind to cancer cells and induce cell death. The LSD Antibody works by blocking the activity of the amide racemase enzyme, which plays a crucial role in fatty acid metabolism and is overexpressed in many types of cancer cells. This inhibition leads to a disruption of cellular processes, ultimately resulting in the death of cancer cells. Furthermore, this monoclonal antibody has shown promising results when used in combination with other anti-cancer drugs or inhibitors, further enhancing its therapeutic potential. With its high specificity and potent cytotoxic effects, the LSD Antibody represents a promising option for targeted cancer therapy.
